Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Principal Investigator
Name
Nicolas Martelin
Degrees
M.B.A., Ph.D.
Institution
Prostperia SAS
Position Title
Managing Director
Email
About this CDAS Project
Study
PLCO (Learn more about this study)
Project ID
PLCO-903
Initial CDAS Request Approval
Jan 27, 2022
Title
Development of a ML algorithm to predict ovarian cancer risk
Summary
Project Summary: Ovarian cancer risk remains difficult to predict and detect. Therefore, 160.000 women worldwide die of ovarian cancer every year(Lozano et al, 2012). Moreover, even in those women who survive ovarian cancer, the consequences of surgery (hysterectomy, salpingoophorectomy, oophorectomy) negatively impact their quality of life.

We want to study how several personal variables (e.g. medical history, family history, lifestyle, etc.) could interact with each other and build a Machine-Learning model around those variables to see whether such a model could improve the prediction of ovarian cancers. Lifestyle and diet components could particularly play a major role in the algorithm's predictive power as recent studies suggest (Liu et al, 2023, Chen et al, 2021).
Aims

- Check whether personal variables such as medical history, family history, lifestyle, and diet. can have some predictive power for ovarian cancer when taken altogether;
- If yes, test whether a predictive score of ovarian cancer risk could be calculated;
- If yes, the project should answer whether such a score could potentially improve ovarian cancer screening.

Collaborators

Nicolas Martelin, Ph.D. - Prostperia SAS
Benjamin Chen - Prostperia SAS